Aurora Expands Medical Cannabis Portfolio in Germany

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer a...

May 01, 2023 | Monday | News
Aquavit Receives FDA Clearance for Two INDs to Initiate Clinical Trials With Its Botulinum Toxin

Aquavit will begin its Phase II/Phase III trials for DTX-023 (aqubotulinumtoxinA) and DTX-024 (aqubotulinumtoxinA with intradermal microinjector) under the...

May 01, 2023 | Monday | News
Pfizer and Astellas' XTANDI® Combo Proves Effective in Reducing Prostate Cancer Metastasis Risk by 58%: Phase 3 EMBARK Trial Results Revealed

Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...

May 01, 2023 | Monday | News
Pfizer Receives AUA Health Science Award

"We are proud to recognize Pfizer Oncology as the recipient of the 2023 Health Science Award," said Edward M. Messing, MD, FACS, president of the AUA. "Pfi...

May 01, 2023 | Monday | News
The Clinician to participate at Digital Health Festival 2023 in Melbourne

As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...

May 01, 2023 | Monday | News
Janssen Reports First Results of TAR-200 and Cetrelimab Study in Non-Muscle-Invasive Bladder Cancer

Study results of novel drug-eluting technology highlight potential durability of TAR-200 in patient population with high unmet need T...

May 01, 2023 | Monday | News
Abbott Completes Acquisition of Cardiovascular Systems, Inc.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...

April 28, 2023 | Friday | News
UCLA Health and CHOC collaborate to enhance access to pediatric congenital cardiac care

"Our shared vision is one program offered at two sites to provide patients with the right care in a location close to home," said Dr. Glen Van Arsdell, who...

April 28, 2023 | Friday | News
Aditum Bio Announces Formation of Vitalli Bio, Focused on Immunological Disorders

Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical...

April 28, 2023 | Friday | News
Celularity presents clinical data on Cynk-001 in Adult AML patients

In patients with relapsed refractory acute myeloid leukemia (R/R AML) treated with a four-dose regimen consisting of 1.8 billion CYNK-001 cells per dose,...

April 27, 2023 | Thursday | News
Corning's New Advanced Flow Pharmaceutical Technology Services Will Help Speed the Creation of Future Medicines

Corning Incorporated  announced the launch of its Advanced Flow Pharmaceutical Technology (AFPT) services business to help contract development m...

April 27, 2023 | Thursday | News
Boehringer Ingelheim Launches Europe's Largest Biotech Development Center

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date B...

April 27, 2023 | Thursday | News
AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

-AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integr...

April 26, 2023 | Wednesday | News
Tofersen's FDA accelerated approval highlights blood neurofilament light chain's significance as surrogate endpoint in neurology trials

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today...

April 26, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close